Description
GDF-15 is a member of the TGF-β superfamily. GDF-15 is expressed as a 308 amino acid precursor that includes a signal peptide, a pro-domain, and a 112 residue mature protein. The secreted pro-domain binds to the extracellular matrix, where it can be activated by multiple enzymes such as furin (PCSK3), PCSK5, PCSK6, MMP-26, and MT1-MMP. GDF-15 is mainly expressed in placenta and prostate. Its expression is low in other tissues such as kidney, bladder, stomach, pancreas, liver, and gall bladder. GDF-15 is highly expressed in cancer cells with high levels detected in serum of cancer patients. GDF-15 has an important role in metabolic syndrome. GDF-15 transgenic mice present a lean phenotype. Furthermore, GDF-15 affects the macrophages in adipose tissue.  Lean adipose tissue is characterized by the presence of anti-inflammatory M2-like macrophages. In obese individuals, adipose tissue show presence of CD8 effector cells and recruitment of inflammatory M1 macrophages. The increase of M1 macrophages over M2 results in metabolic changes, increase of TNFα, induction of glucose intolerance, and insulin insensitivity. GDF-15 binds to the GDNF receptor family member alpha like (GFRAL) which interacts with the co-receptor RET.
Specifications

General

Verified ReactivityHuman
Antibody TypeMonoclonal
Host SpeciesMouse
ImmunogenRecombinant Human GDF-15
Formulation0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
PreparationThe Ultra-LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
ConcentrationThe antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & HandlingThe antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF™ solution contains no preservative; handle under aseptic conditions.
ApplicationBlock - Quality tested
Recommended UsageEach lot of this antibody is quality control tested by blocking the binding of 1 ng/mL human GDF-15 (Cat. No. 799204) to 0.1 µg/mL immobilized recombinant GDNF receptor-alpha-like. ND50 range: 0.14 - 0.9 µg/mL.
RRIDAB_3683502 (BioLegend Cat. No. 695453) AB_3683502 (BioLegend Cat. No. 695454)
StructureHomodimer
DistributionMacrophages, adipocytes, cardiomyocytes, endothelial, and vascular smooth muscle cells. Expressed mainly in placenta and prostate.
FunctionRegulates metabolism, appetite, cell survival, and immune tolerance. Regulated by androgens and calcitriol in prostate. Induced by inflammatory cytokines: IL-1b, TNFa, IL-2, and G-CSF.
InteractionNeurons, gastric cancer cells, normal gastric mucosal cells, adipose tissue
Ligand/ReceptorGFRAL
Cell TypeEpithelial cells, Macrophages, Neurons
Biology AreaCancer Biomarkers, Immuno-Oncology
Molecular FamilyGrowth Factors
Antigen ReferencesBootcov MR, et al. 1997. Proc Natl Acad Sci USA. 94:11514. Emmerson PJ, et al. 2017. Nat Med. 23:1215-1219. Li J, et al. 2018. Mol Cell Biol. 38:e00099-18. Li S, et al. 2014. J Clin Endocrinol Metab. 99:E2277. Nishimura S, et al. 2009. Nat Med. 15:914-20. Lackey DE, et al. 2016. Nat Rev Endocrinol. 12:15-28. Buchholz K, et al. 2021. J Cancer. 12:4698-4709.
Gene ID9518
UniProtView information about GDF-15 on UniProt.org
CloneA22095G
Regulatory StatusRUO
Other NamesMIC-1, NAG-1, pTGFB, PDF, PLAB
IsotypeMouse IgG2a, κ
Biolegend 695453 Ultra-LEAF Purified anti-human GDF-15 Antibody | IRIGHT